Conditions: Seasonal Allergic Conjunctivitis
Keywords: ocular allergy
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 300
Healthy volunteers: no

Brief summary:
This study is to evaluate the safety and efficacy of Alrex (LE ophthalmic suspension, 0.2%) versus Patanol (olopatadine hydrochloride ophthalmic solution, 0.1%) in the temporary relief of the signs and symptoms of Seasonal Allergic Conjunctivitis (SAC).

Detailed description:

Arms:
arm 1: Ophthalmic formulation containing the active ingredient loteprednol etabonate, 0.2% arm 2: Ophthalmic solution containing olopatadine, 0.1%

Interventions: intervention 1: Loteprednol etabonate 0.2% intervention 2: Olopatadine 0.1%
Intervention descriptions: intervention 1: 1 drop of Alrex 4 times daily (QID) in both eyes at approximately 4 hour intervals for 2 weeks. intervention 2: 1 drop of Patanol 2 times daily (BID)at intervals of 6-8 hours or more for 2 weeks.

Protocol document: